Literature DB >> 1419606

Contribution of 3H-thymidine labelling index and flow cytometric S-phase in predicting survival of patients with non-Hodgkin's lymphoma.

A Costa1, R Silvestrini, R Giardini, G Messina-Gabrielli, P Boracchi, S Veneroni.   

Abstract

The 3H-thymidine labelling index (3H-dT LI) of cell suspensions from fresh material and the flow cytometric S-phase (FCM-S) of nuclei recovered from paraffin blocks were determined on the same pathologic lymph node specimen for 190 non-Hodgkin's lymphomas (NHLs). FCM-S was defined by a planimetric method and by an optimization procedure. Poor correlation coefficients were observed among the three cell kinetic variables. All three cell kinetic variables were significant indicators of 8-year survival and median survival time. The life-regression procedure evidenced a significant relative contribution of 3H-dT LI and FCM-S, thus suggesting a different biologic meaning of the two cell kinetic variables. This finding was further supported by evidence that simultaneous use of 3H-dT LI and FCM-S can identify groups of patients with different survival better than when either modality is used alone. Multivariate analysis indicated that the risk groups as defined by cell kinetic variables are predictors of survival even in the presence of established factors such as histology and stage.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1419606      PMCID: PMC1977419          DOI: 10.1038/bjc.1992.337

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  27 in total

1.  Prognostic significance of flow cytometry studies in B-cell non-Hodgkin lymphoma.

Authors:  S Rehn; B Glimelius; P Strang; C Sundström; B Tribukait
Journal:  Hematol Oncol       Date:  1990 Jan-Feb       Impact factor: 5.271

Review 2.  How to use prognostic factors in axillary node-negative breast cancer patients.

Authors:  W L McGuire; A K Tandon; D C Allred; G C Chamness; G M Clark
Journal:  J Natl Cancer Inst       Date:  1990-06-20       Impact factor: 13.506

3.  Uptake of thymidine in lymphoma cells obtained through fine-needle aspiration biopsy. Relation to prognosis in non-Hodgkin's lymphomas.

Authors:  L Brandt; H Olsson; M Monti
Journal:  Eur J Cancer Clin Oncol       Date:  1981-11

4.  Prognostic significance of DNA-analysis by flow cytometry in non-Hodgkin's lymphoma.

Authors:  G Roos; U Dige; P Lenner; J Lindh; H Johansson
Journal:  Hematol Oncol       Date:  1985 Oct-Dec       Impact factor: 5.271

5.  3H-thymidine-labeling index as a prognostic indicator in node-positive breast cancer.

Authors:  R Silvestrini; M G Daidone; P Valagussa; G Di Fronzo; G Mezzanotte; L Mariani; G Bonadonna
Journal:  J Clin Oncol       Date:  1990-08       Impact factor: 44.544

6.  Prognostic implications of cell kinetics, histopathology and pathologic stage in non-Hodgkin's lymphomas.

Authors:  R Silvestrini; A Costa; R Giardini; P Boracchi; G Del Bino; E Marubini; F Rilke
Journal:  Hematol Oncol       Date:  1989 Nov-Dec       Impact factor: 5.271

Review 7.  Treatment of patients with aggressive lymphomas: an overview.

Authors:  W J Urba; P L Duffey; D L Longo
Journal:  J Natl Cancer Inst Monogr       Date:  1990

8.  Biologic progression in non-Hodgkin's lymphoma. A flow cytometric study.

Authors:  H Joensuu; P J Klemi; S Jalkanen
Journal:  Cancer       Date:  1990-06-01       Impact factor: 6.860

9.  3H-thymidine uptake in B cell lymphomas--relationship to treatment response and survival.

Authors:  S Kvaløy; P F Marton; O Kaalhus; J Høie; A Foss-Abrahamsen; T Godal
Journal:  Scand J Haematol       Date:  1985-05

10.  Labeling index as a prognostic marker in non-Hodgkin's lymphomas.

Authors:  A Costa; G Bonadonna; E Villa; P Valagussa; R Silvestrini
Journal:  J Natl Cancer Inst       Date:  1981-01       Impact factor: 13.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.